Skip to content
Disclosery

Fund Evaluation Group, LLC: CATH position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Fund Evaluation Group, LLC on CATH, newest first. How the timeline and the estimate are built.

Fund Evaluation Group, LLC held 976,483 CATH shares at 2026-06-30 per its 13F-HR filed 2026-08-07.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 976,483 shares
    Change vs previous 13F +238,027 shares

    2.33% of the 13F portfolio, value $86,418,746.

    13F-HR 0001420506-26-001466 filed by Fund Evaluation Group, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 738,456 shares
    Change vs previous 13F +52,805 shares

    1.77% of the 13F portfolio, value $57,710,336.

    13F-HR 0001420506-26-000854 filed by Fund Evaluation Group, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 685,651 shares
    Change vs previous 13F -47,588 shares

    1.86% of the 13F portfolio, value $56,378,819.

    13F-HR 0001420506-26-000294 filed by Fund Evaluation Group, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 733,239 shares
    Change vs previous 13F +257,166 shares

    2.15% of the 13F portfolio, value $59,435,253.

    13F-HR 0001420506-25-003080 filed by Fund Evaluation Group, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 476,073 shares
    Change vs previous 13F -10,297 shares

    1.39% of the 13F portfolio, value $35,919,708.

    13F-HR 0001420506-25-001768 filed by Fund Evaluation Group, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 486,370 shares
    Change vs previous 13F +113,169 shares

    1.42% of the 13F portfolio, value $32,849,430.

    13F-HR 0001420506-25-000826 filed by Fund Evaluation Group, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 373,201 shares
    Change vs previous 13F +74,708 shares

    1.24% of the 13F portfolio, value $26,437,559.

    13F-HR 0001420506-25-000306 filed by Fund Evaluation Group, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 298,493 shares
    Change vs previous 13F not available

    1.15% of the 13F portfolio, value $20,712,000.

    13F-HR 0001356249-24-000008 filed by Fund Evaluation Group, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).